ArticleNature communications2026
De novo design of peptides localizing at the interface of biomolecular condensates.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates.Angewandte Chemie (International ed. in English) · 2026Review
- Ki-67 shapes the nucleolus by anchoring chromatin via its amphiphilic properties.The EMBO journal · 2026Article
- Protein codes and mobility together shape cellular function and disease.Trends in biochemical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The interface of biomolecular condensates plays a key role in processes such as protein aggregation and biochemical reactions, making it an attractive target for engineering condensates. However, the molecular grammar that drives preferential localization to condensate interfaces remains poorly understood. Here, we develop a computational pipeline that integrates high-throughput coarse-grained simulations, machine learning, and mixed-integer linear programming to design peptides that partition at the interfaces of defined condensate targets. We validated the workflow by designing and synthesizing peptides that localize at the interface of three distinct condensates formed by intrinsically disordered protein regions. These peptides exhibit surfactant-like architectures. Specifically, one tail inserts into the condensate and is enriched in aromatic residues, while the opposite tail is excluded from the dense phase, with its sequence varying according to the scaffold's net charge. Overall, our pipeline offers a general strategy for rationally designing interface-localizing peptides and for unraveling the governing design principles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.